Safety and Efficacy of SOF/VEL/VOX FDC for 8 Weeks and SOF/VEL for 12 Weeks in Adults Chronic Genotype 3 HCV Infection and Cirrhosis
Clinical trial NCT02639338 · COMPLETED
Trial details
- NCT number
- NCT02639338
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-23
- Primary completion
- 2016-10-12
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.